Skip to content

Clinical trials

Phase 1 Carcinoma, Hepatocellular trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1 Country / region: Japan Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20111
20122
20131
20141
20153
20161
20174
20181
20193
20203
20212
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting5
Active, not recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Pfizer4
Eisai Co., Ltd.3
AstraZeneca2
Eli Lilly and Company2
Sumitomo Pharma Co., Ltd.2
Bayer1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Chiome Bioscience Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular28
Neoplasms9
Carcinoma, Non-Small-Cell Lung7
Squamous Cell Carcinoma of Head and Neck6
Triple Negative Breast Neoplasms6
Stomach Neoplasms5
Carcinoma, Merkel Cell4
Melanoma4
Small Cell Lung Carcinoma4
Uterine Cervical Neoplasms4

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.